Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York.
Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York.
Gastrointest Endosc Clin N Am. 2024 Oct;34(4):805-818. doi: 10.1016/j.giec.2024.07.001.
With the growing global burden of obesity, the field of endobariatrics has emerged as a promising alternative, filling the void between lifestyle interventions with modest efficacy and more invasive surgical procedures. This article explores the latest advancements in endobariatric therapies, encompassing endoscopic sleeve gastroplasty (ESG), intragastric balloons (IGB), endoscopic metabolic therapies, and promising pharmacologic and surgical combination approaches that integrate multiple therapeutic modalities. It also outlines the critical factors and strategic considerations necessary for the successful integration of endobariatric interventions into clinical practice.
随着肥胖症在全球负担的不断增加，内镜减肥领域作为一种有前途的替代方法出现了，填补了生活方式干预效果适度和更具侵入性手术之间的空白。本文探讨了内镜减肥治疗的最新进展，包括内镜袖状胃成形术（ESG）、胃内球囊（IGB）、内镜代谢治疗以及有前途的药物和手术联合方法，这些方法整合了多种治疗模式。它还概述了将内镜减肥干预成功整合到临床实践中所需的关键因素和战略考虑。
